Maternal septic shock due to Acinetobacter lwoffii infection:a case report.
Acinetobacter lwoffii
case report
chorioamnionitis
septic shock
Journal
Fukushima journal of medical science
ISSN: 2185-4610
Titre abrégé: Fukushima J Med Sci
Pays: Japan
ID NLM: 0374626
Informations de publication
Date de publication:
15 Nov 2023
15 Nov 2023
Historique:
medline:
17
11
2023
pubmed:
28
9
2023
entrez:
28
9
2023
Statut:
ppublish
Résumé
The incidence of Acinetobacter infections has increased in recent years. Acinetobacter infections are resistant to most antibiotics and can be found in hospitalized patients. Pregnancies complicated by severe sepsis or septic shock are associated with a higher rate of preterm labor and delivery, fetal infection, and operative delivery. This case report describes septic shock due to Acinetobacter lwoffii infection in the 31st week of gestation. A 47-year-old woman, with a gestation of 31 weeks and one day, presented with a fever, and signs of bacterial infection on laboratory tests. Although the patient was started on tazobactam/piperacillin, she went into septic shock, and was transferred to our hospital. Cesarean section was performed at a gestation of 31 weeks and 4 days because of severe maternal pneumonia and non-reassuring fetal status. A. lwoffii was detected in blood cultures collected at the previous hospital, and susceptibility to piperacillin and meropenem to A. lwoffii was confirmed. The pneumonia responded to antibiotic treatment and there were no findings of infection in the neonate. Maternal sepsis is an infrequent but important complication, causing significant maternal and fetal morbidity and fetal and neonatal mortality; therefore, early antibiotic therapy is required to improve the clinical outcome.
Identifiants
pubmed: 37766560
doi: 10.5387/fms.2022-43
pmc: PMC10694513
doi:
Substances chimiques
Anti-Bacterial Agents
0
Piperacillin
X00B0D5O0E
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
191-196Références
Eur J Clin Microbiol Infect Dis. 2000 Jul;19(7):501-5
pubmed: 10968320
Obstet Gynecol Clin North Am. 2007 Sep;34(3):459-79, xi
pubmed: 17921010
Clin Infect Dis. 2006 Mar 1;42(5):692-9
pubmed: 16447117
Best Pract Res Clin Obstet Gynaecol. 2013 Aug;27(4):583-95
pubmed: 23639681
BJOG. 2015 Apr;122(5):663-71
pubmed: 24862293
Crit Care. 2006;10(2):R48
pubmed: 16563184
AJP Rep. 2013 May;3(1):51-6
pubmed: 23943711
Rev Bras Ter Intensiva. 2013 Oct-Dec;25(4):334-44
pubmed: 24553516
Clin Infect Dis. 1995 Jan;20(1):205-6
pubmed: 7727663
Am Rev Respir Dis. 1988 Mar;137(3):668-72
pubmed: 3345045
Infect Disord Drug Targets. 2015;15(3):184-8
pubmed: 26307173
BJOG. 2011 Mar;118 Suppl 1:1-203
pubmed: 21356004
Obstet Gynecol. 2012 Sep;120(3):689-706
pubmed: 22914482
Obstet Gynecol Clin North Am. 2013 Mar;40(1):69-87
pubmed: 23466138
Int J Antimicrob Agents. 2010 Mar;35(3):219-26
pubmed: 20047818
Int J Antimicrob Agents. 2011 Feb;37(2):102-9
pubmed: 21130607
Arch Gynecol Obstet. 2010 Jan;281(1):171-4
pubmed: 19462176
Int J Obstet Anesth. 2012 Jan;21(1):56-67
pubmed: 22168972